Multifunctional nanodiamonds-based nanoplatform for enhanced mild-temperature photothermal/chemo combination therapy of triple negative breast cancer via autophagy regulation strategy

Nanoscale ◽  
2021 ◽  
Author(s):  
Xinyue Cui ◽  
Zhaoyuan Liang ◽  
Jianqing Lu ◽  
Xuan Wang ◽  
Fan Jia ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Combination Therapy ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Therapeutic Strategies ◽  
Biological Behavior ◽  
Therapeutic Resistance ◽  
Multiple Treatments ◽  
Mild Temperature

Due to the aggressive biological behavior, lacking of specific targets and unconquered therapeutic resistance of Triple Negative Breast Cancer (TNBC), current therapeutic strategies were still limited. Combining multiple treatments have...

Precision combination therapy for triple negative breast cancer via biomimetic polydopamine polymer core-shell nanostructures

Biomaterials ◽  
2017 ◽  
Vol 113 ◽  
pp. 243-252 ◽  
Author(s):  
Yanping Ding ◽  
Shishuai Su ◽  
Ruirui Zhang ◽  
Leihou Shao ◽  
Yinlong Zhang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Combination Therapy ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Core Shell ◽  
Shell Nanostructures

Abstract 1561: Age impacts response to paclitaxel-anti-PDL1 combination therapy in triple-negative breast cancer

2021 ◽  
Author(s):  
Milos Spasic ◽  
Gregory J. Goreczny ◽  
Qiuchen Guo ◽  
John N. Hutchinson ◽  
Rachel A. Freedman ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Combination Therapy ◽  
Triple Negative Breast Cancer ◽  
Triple Negative

scholarly journals Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy

2018 ◽  
Vol 25 (6) ◽  
pp. 1838-1850 ◽  
Author(s):  
Pierre Foidart ◽  
Cassandre Yip ◽  
Jean Radermacher ◽  
Silvia Blacher ◽  
Mehdi Lienard ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Combination Therapy ◽  
Triple Negative Breast Cancer ◽  
Triple Negative

scholarly journals MAPK4 silencing together with a PARP1 inhibitor as a combination therapy in triple‑negative breast cancer cells

2021 ◽  
Vol 24 (2) ◽  
Author(s):  
Xiaoqi Zeng ◽  
Shanshan Jiang ◽  
Simin Ruan ◽  
Zhaoze Guo ◽  
Jingyun Guo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Combination Therapy ◽  
Cancer Cells ◽  
Triple Negative Breast Cancer ◽  
Breast Cancer Cells ◽  
Triple Negative

scholarly journals Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer

Oncotarget ◽  
2016 ◽  
Vol 7 (45) ◽  
pp. 73618-73637 ◽  
Author(s):  
Abderrahim El Guerrab ◽  
Mahchid Bamdad ◽  
Fabrice Kwiatkowski ◽  
Yves-Jean Bignon ◽  
Frédérique Penault-Llorca ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Monoclonal Antibodies ◽  
Combination Therapy ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Triple Negative Breast Cancer ◽  
Kinase Inhibitors ◽  
Triple Negative ◽  
Egfr Tyrosine Kinase ◽  
Egfr Tyrosine Kinase Inhibitors

scholarly journals Therapeutic Strategies in Triple-Negative Breast Cancer

Breast Care ◽  
2017 ◽  
Vol 12 (1) ◽  
pp. 6-7 ◽  
Author(s):  
Angelo Paradiso ◽  
Christian F. Singer
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Therapeutic Strategies

Abstract 2160: Targeting SMC1 in combination therapy for triple negative breast cancer

2016 ◽  
Author(s):  
Sushma Yadav ◽  
David Berz ◽  
George Somlo ◽  
Kimlin Ashing ◽  
Yate-Ching Yuan ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Combination Therapy ◽  
Triple Negative Breast Cancer ◽  
Triple Negative
Sign in / Sign up

Export Citation Format

Share Document